New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease
Stock Information for Lexicon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.